Syndax Pharmaceuticals grants inducement awards for up to 175,000 shares
Syndax Pharmaceuticals announced inducement grants under NASDAQ Listing Rule 5635(c)(4) on Sept. 1, 2026, to purchase up to 175,000 shares of common stock.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.